EVM
AMED

Eaton Vance Management’s Amedisys AMED Stock Holding History

Eaton Vance Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$801K Buy
8,277
+91
+1% +$10.9K ﹤0.01% 1268
2022
Q2 		$860K Sell
8,186
-12,822
-61% -$1.64M ﹤0.01% 1284
2022
Q1 		$3.62M Buy
21,008
+8,731
+71% +$1.3M ﹤0.01% 983
2021
Q4 		$1.99M Buy
12,277
+3,741
+44% +$601K ﹤0.01% 1026
2021
Q3 		$1.14M Sell
8,536
-414
-5% -$86.1K ﹤0.01% 1063
2021
Q2 		$2.19M Buy
8,950
+1,565
+21% +$411K ﹤0.01% 992
2021
Q1 		$1.96M Sell
7,385
-473
-6% -$133K ﹤0.01% 980
2020
Q4 		$2.31M Sell
7,858
-10,371
-57% -$2.66M ﹤0.01% 896
2020
Q3 		$4.31M Sell
18,229
-75,758
-81% -$17.2M 0.01% 669
2020
Q2 		$18.7M Sell
93,987
-13,107
-12% -$2.44M 0.04% 344
2020
Q1 		$19.7M Sell
107,094
-108,784
-50% -$19.4M 0.05% 306
2019
Q4 		$36M Sell
215,878
-13,287
-6% -$1.98M 0.07% 239
2019
Q3 		$30M Buy
229,165
+19,865
+9% +$2.59M 0.06% 247
2019
Q2 		$25.4M Buy
209,300
+22,994
+12% +$2.73M 0.06% 268
2019
Q1 		$23M Buy
186,306
+13,994
+8% +$1.76M 0.05% 272
2018
Q4 		$20.2M Sell
172,312
-22,867
-12% -$2.7M 0.05% 263
2018
Q3 		$24.4M Sell
195,179
-101,689
-34% -$11.2M 0.05% 257
2018
Q2 		$25.4M Sell
296,868
-392,238
-57% -$28.8M 0.06% 252
2018
Q1 		$41.6M Buy
689,106
+350,618
+104% +$20M 0.05% 268
2017
Q4 		$17.8M Buy
338,488
+136,001
+67% +$7.17M 0.04% 293
2017
Q3 		$11.3M Buy
202,487
+19,780
+11% +$1.05M 0.03% 354
2017
Q2 		$11.5M Buy
182,707
+15,462
+9% +$900K 0.03% 346
2017
Q1 		$8.54M Buy
+167,245
New +$7.98M 0.02% 380

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Eaton Vance Management's AMED Position: Q3 2022 in Review

Eaton Vance Management increased its Amedisys (AMED) stake by 1.1% in Q3 2022, buying an estimated $10.9K and bringing the position to 8,277 shares worth $801K. The position accounts for ﹤0.01% of the portfolio, ranked #1268.

Eaton Vance Management first reported a position in AMED in Q1 2017 and has held it in 23 quarters since. The position peaked at $41.6M in Q1 2018. 287 funds tracked by Wall St. Rank hold AMED as of Q3 2022.

  • Eaton Vance Management held 8,277 shares of Amedisys worth $801K as of Q3 2022.
  • Eaton Vance Management bought 91 Amedisys shares in Q3 2022, an estimated $10.9K.
  • Amedisys made up ﹤0.01% of Eaton Vance Management's portfolio in Q3 2022, its #1268 holding.
  • Eaton Vance Management first reported a position in Amedisys in Q1 2017 and has held it in 23 quarters since.
  • Eaton Vance Management's Amedisys position peaked at $41.6M in Q1 2018.
  • 287 funds tracked by Wall St. Rank held Amedisys as of Q3 2022.

Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.